Source: Okayama University (JAPAN), Public Relations and Information Strategy
For immediate release: 03 March 2017
Okayama University research: Overloading of protein localization triggers cellular defects
(Okayama, 03 March) Researchers at Okayama University report in Scientific Reports how the overloading of protein transport mechanisms affects cell functioning. Over-expression of different types of target proteins leads to cellular growth defects, and the mechanism for transporting proteins out of a cell nucleus has the lowest over-expression tolerance.
Transporting proteins to where they need to be within an organism’s cell — protein targeting — costs resources. Too much expression (the synthesis and subsequent handling by the cell) of proteins that require transportation may limit the cell’s resources for moving other proteins around, potentially hampering proper cell functioning. A team of researchers from Okayama University led by Hisao Moriya has now investigated in detail what actually happens when protein-targeting resources become overloaded, and concluded that overloading situations lead to cellular growth defects.
For protein targeting, organisms rely on so-called signals: particular amino acid sequences within proteins that act as labels. Mitochondrial targeting signals (MTSs), signal sequences (SSs), nuclear localization signals (NLSs) and nuclear export signals (NESs) are important labels that drive proteins to mitochondria, to the endoplasmic reticulum, into the cell nucleus, and out of it, respectively. Moriya and colleagues attached signals of these types to green fluorescent proteins (GFPs) and, using a method they had developed before (‘genetic tug of war’), measured the expression limits of the modified GFPs.
By comparing results for signal-modified and unmodified GFPs, the researchers first observed that the added signals reduce expression limits of the modified GFPs — except for the NLS modification. NESs had the lowest limit; this is due to the exhaustion of a protein known as chromosomal maintenance 1 (Crm1) when overloading nuclear export processes mediated by Crm1. For MTS- and SS-modified GFPs, specific limiting factors could not be identified yet.
Moriya and colleagues assessed the physiological consequences of the reduced protein expression capabilities by gene analysis of the sets of messenger-RNA molecules (the transcriptomes) in the cells expressing modified GFP; they found that the artificially applied signals trigger various defects in cellular processes, similar to what happens with GFPs modified with a misfolding mutant.
The scientists also managed to obtain estimates for the critical amount of protein causing growth defects, via measurements of the number of modified GFPs produced. For MTS-, NES- and SS-modified GFPs the limits were 4%, 1% and 0.7%, respectively (the percentages are relative to the amount of unmodified GFP produced).
The findings of Moriya and colleagues show that the overloading of transport machineries in cells has various knock-on effects on cellular functioning. As the researchers point out: “understanding and controlling process overloads is beneficial for disease treatment and cellular engineering.”
Genetic tug of war
Developed in the group of Hisao Moriya at Okayama University, the ‘genetic tug of war (gTOW)’ screening method enables estimating the over-expression limit of a particular protein. The method consists of first implanting the gene encoding the protein in yeast (Saccharomyces cerevisiae) cells, then generating copies of the gene and, finally, determining the copy-number limit; the latter serves as a proxy for the protein’s expression limit. The researchers used the gTOW technique for investigating the expression limit of various signal-modified green fluorescent proteins (GFPs).
Green fluorescent protein
Green fluorescent protein (GFP) displays green fluorescence upon exposure to blue-to-ultraviolet light. The GFP gene is often used in biomedical protein expression experiments. For instance, it has been shown that the GFP gene can be expressed in specific cells, particular organs, or whole organisms. Moriya and colleagues expressed GFPs modified with localization signals in yeast cells; they exploited the fluorescence property of GFPs for investigating the effects of the modifications on cells, including growth defects.
Reiko Kintaka, Koji Makanae, and Hisao Moriya. Cellular growth defects triggered by an overload of protein localization processes. Scientific Reports, 6, Article Number 31774, 2016.
Reference (Okayama Univ. e-Bulletin): Associate Professor Moriya’s team
Measuring the copy number limits of all genes in budding yeast. – First time ever for any organisms –. (2013)
Associate Professor Hisao Moriya, Ph.D.
Research Core for Interdisciplinary Sciences, Okayama University,
3-1-1 Tsushimanaka, Kita-ku, Okayama 700-8530, Japan
e-mail : hisaom(a) cc.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.
1-1-1 Tsushima-naka , Kita-ku , Okayama 700-8530, Japan
Public Relations and Information Strategy
E-mail: www-adm (a) adm.okayama-u.ac.jp
For inquiries, please contact us by replacing (a) with the @ mark.
Okayama Univ. e-Bulletin: //www.okayama-u.ac.jp/user/kouhou/ebulletin/
Okayama Univ. e-Bulletin (PDF Issues): //www.okayama-u.ac.jp/user/kouhou/ebulletin/
About Okayama University (You Tube): https://www.youtube.com/watch?v=iDL1coqPRYIOkayama University Image Movie (You Tube): https://www.youtube.com/watch?v=_WnbJVk2elA
Okayama University Medical Research Updates （OU-MRU）
Vol.1：Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells from blood samples for genetic testingVol.2：Ensuring a cool recovery from cardiac arrestVol.3：Organ regeneration research leaps forwardVol.4：Cardiac mechanosensitive integratorVol.5：Cell injections get to the heart of congenital defectsVol.6：Fourth key molecule identified in bone developmentVol.7：Anticancer virus solution provides an alternative to surgeryVol.8：Light-responsive dye stimulates sight in genetically blind patientsVol.9：Diabetes drug helps towards immunity against cancerVol.10：Enzyme-inhibitors treat drug-resistant epilepsyVol.11：Compound-protein combination shows promise for arthritis treatmentVol.12：Molecular features of the circadian clock system in fruit fliesVol.13：Peptide directs artificial tissue growthVol.14：Simplified boron compound may treat brain tumoursVol.15：Metamaterial absorbers for infrared inspection technologiesVol.16：Epigenetics research traces how crickets restore lost limbsVol.17：Cell research shows pathway for suppressing hepatitis B virusVol.18：Therapeutic protein targets liver diseaseVol.19：Study links signalling protein to osteoarthritisVol.20：Lack of enzyme promotes fatty liver disease in thin patientsVol.21：Combined gene transduction and light therapy targets gastric cancerVol.22：Medical supportive device for hemodialysis catheter punctureVol.23：Development of low cost oral inactivated vaccines for dysenteryVol.24：Sticky molecules to tackle obesity and diabetesVol.25：Self-administered aroma foot massage may reduce symptoms of anxietyVol.26：Protein for preventing heart failureVol.27：Keeping cells in shape to fight sepsisVol.28：Viral-based therapy for bone cancerVol.29：Photoreactive compound allows protein synthesis control with lightVol.30：Cancer stem cells’ role in tumor growth revealedVol.31：Prevention of RNA virus replicationVol.32：Enzyme target for slowing bladder cancer invasionVol.33：Attacking tumors from the insideVol.34：Novel mouse model for studying pancreatic cancerVol.35：Potential cause of Lafora disease revealed